You are here

  • Home
  • Archive
  • Volume 8, Issue 2
  • FcγRIIB engagement drives agonistic activity of Fc-engineered αOX40 antibody to stimulate human tumor-infiltrating T cells

Article metrics

Article menu

Download PDFPDF

XML
Clinical/translational cancer immunotherapy
Original research
FcγRIIB engagement drives agonistic activity of Fc-engineered αOX40 antibody to stimulate human tumor-infiltrating T cells

 

Online download statistics by month:

Online download statistics by month: September 2020 to March 2024

AbstractFullPdf
Sep 2020389389122
Oct 202020520585
Nov 2020626337
Dec 2020373710
Jan 2021505019
Feb 2021525220
Mar 2021555524
Apr 2021474714
May 2021323215
Jun 2021414112
Jul 2021525223
Aug 2021434316
Sep 2021515135
Oct 2021535348
Nov 2021565660
Dec 2021606023
Jan 2022506519
Feb 2022374012
Mar 2022546325
Apr 2022404113
May 2022434318
Jun 2022495024
Jul 2022474719
Aug 2022606221
Sep 2022535634
Oct 2022444521
Nov 2022363615
Dec 2022282813
Jan 202331318
Feb 202353536
Mar 2023212316
Apr 2023191912
May 2023313112
Jun 202321215
Jul 2023272712
Aug 2023404120
Sep 202321218
Oct 202323237
Nov 2023545415
Dec 2023434315
Jan 2024222315
Feb 2024363815
Mar 20243333220
Total230123431183